Premium
Axonal dysfunction prior to neuropathy onset in type 1 diabetes
Author(s) -
Arnold Ria,
Kwai Natalie,
Lin Cindy S.Y.,
Poynten Ann M.,
Kiernan Matthew C.,
Krishnan Arun V.
Publication year - 2013
Publication title -
diabetes/metabolism research and reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.307
H-Index - 110
eISSN - 1520-7560
pISSN - 1520-7552
DOI - 10.1002/dmrr.2360
Subject(s) - medicine , type 2 diabetes , diabetes mellitus , refractory period , diabetic neuropathy , type 1 diabetes , endocrinology , case control study , cohort , pathophysiology , gastroenterology
Background The present study was undertaken to determine whether there were changes evident in axonal membrane function prior to the onset of neuropathy in patients with type 1 and type 2 diabetes. Methods From a cohort of 110 consecutive referrals, nerve excitability was investigated in 40 diabetic patients without clinical evidence of neuropathy (20 type 1 diabetic patients and 20 type 2 diabetic patients). Groups were matched for gender, disease duration and HbA 1c . Studies were also undertaken in two control groups, younger controls and older controls, matched for age and gender with the diabetic cohorts. Results Subjects with type 1 diabetes demonstrated significant nerve excitability abnormalities when compared with younger normal controls. Specifically, type 1 subjects showed a significant reduction at multiple time points in both depolarising and hyperpolarising threshold electrotonus. Additionally, the relative refractory period was prolonged (type 1, 3.19 ms; younger normal controls, 3.0 ms; p < 0.05) and superexcitability was reduced (type 1, −23.12%; younger normal controls, −26.37%; p < 0.05), consistent with axonal membrane depolarisation. Correlations were identified in type 1 patients between disease duration and nerve excitability parameters, including the relative refractory period ( r = −0.533, p < 0.05). In contrast, only minor non‐specific changes were noted in the type 2 group. Discussion This study provides clear evidence of altered axonal function in patients with type 1 diabetes in the absence of clinical neuropathy. These findings suggest that altered axonal membrane potential may precede neuropathy onset in type 1 diabetes and as such may indicate a window of opportunity to intervene and potentially reverse axonal membrane dysfunction before the development of irreversible neuropathy. Copyright © 2012 John Wiley & Sons, Ltd.